Studies have shown that active fund managers routinely underperform the S&P500 index*​

Annovis Bio, Inc. (NYSE: ANVS)

ANVS Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
264.90%

ANVS Stock Analysis

ANVS PE Ratio:

ANVS PEG Ratio: Not Available

ANVS Forward EPS Growth (12 month): 0.00%

ANVS PS Ratio:

ANVS PSG Ratio: Not Available

ANVS Forward Revenue Growth (12 month): 0.00%

ANVS Articles

No data was found